Trial Profile
Clinical Trials Insight: 700047804
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Aug 2009
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 17 Aug 2009 New trial record.